NCIt definition : A fully human IgG1 monoclonal antibody directed against intercellular adhesion molecule-1
(ICAM-1 or CD54), with potential antineoplastic activity. Bersanlimab selectively
binds to the adhesion protein ICAM-1, which may result in antibody-dependent cellular
cytotoxicity (ADCC), hyper-cross-linking-induced apoptosis, and a decrease in cellular
proliferation of ICAM-1-expressing tumor cells. ICAM-1, normally expressed on leukocytes
and endothelial cells, may be overexpressed in a variety of cancers.;
UNII : MP3N1L4OR6;
CAS number : 1987854-08-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1987854-08-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;